Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))— 510(k) K252160

Substantially Equivalent

Persyst Development, LLC

FDA 510(k) clearance K252160 for Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15)), Substantially Equivalent on 2025-10-31. Applicant: Persyst Development, LLC.

Clearance details

Applicant
Persyst Development, LLC
Product code
Code OMB
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Solana Beach, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.